Letter by Noubiap and Kamtchum-Tatuene Regarding Article, "PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial".

Letter by Noubiap and Kamtchum-Tatuene Regarding Article, "PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial".